Mild Neurocognitive Disorder
14
5
5
4
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 59/100
14.3%
2 terminated out of 14 trials
66.7%
-19.8% vs benchmark
0%
0 trials in Phase 3/4
50%
2 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (14)
Endovascular Therapy Versus Best Medical Treatment for Acute Large Vessel Occlusion Stroke With Low NIHSS
Brain Stimulation and Cognitive Training for MCI
Pramipexole Versus Escitalopram to Treat Major Depressive Disorder (MDD) and Comorbid MDD With Mild Neurocognitive Disorder (MND) in Persons With HIV
C-SMART: Cognitive Strategies, Mindfulness, and Rehabilitation Therapy for Patients With Primary Brain Tumors
tFUS for Memory in mNCD and Healthy Adults
Impact of Intensive Computerized Cognitive Training
Deep rTMS for Mild Neurocognitive Disorder in Older Adults
Noninvasive Brain Stimulation for Mild Cognitive Impairment
Effectiveness of a Novel Exergame-Based Training Concept for Older Adults With Mild Neurocognitive Disorder
Feasibility of a Novel Exergame-Based Training Concept for Older Adults With Mild Neurocognitive Disorder
Long Term Transcranial Pulse Stimulation (TPS) on Older Adults With Mild Neurocognitive Disorder (NCD)
Physical Exercise And Cognitive Engagement Outcomes for Mild Neurocognitive Disorder
Transcranial Pulse Stimulation Open-label Self-controlled Trial For Mild Neurocognitive Disorder
Cognitive Training With and Without tDCS to Improve Cognition in HIV